Company & Sponsor Intelligence
Drexel University College of Medicine
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed1
Countries1
Therapeutic footprint
unclassified
Indexed studies
NCT01318408Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
unclassified · United StatesPHASE4
unclassified · United StatesPHASE4
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →